| This is a PAID ADVERTISEMENT provided to our customers. Although we have sent you this email, Schaeffer's Investment Research does not endorse this product nor is it responsible for the content of this ad. Furthermore, we make no guarantee or warranty about what is advertised below. | | | | Dear Friend, Can you imagine doubling your money in one morning? It's happened 3 times in the past 6 months with takeovers. On May 4th, 2020, investors made 154% in one morning - when Stemline Therapeutics was taken over. On March 4, 2020, investors made 147% in one morning - when Forty-Seven was taken over by Gilead. And on December 9, 2019 investors made 100% in one morning - when Arqule was taken over by Merck. Big Pharma bought each of these companies because of their new cancer treatments. And takeover master Dylan Jovine has just released the next biotech he thinks gets taken over. This tiny biotech recently signed a deal with Bristol-Myers - because of their powerful new cancer treatment. Dylan Jovine is an expert when it comes to picking biotech takeovers: On August 19, 2019, investors made 144% in one morning - when Array Biopharma was taken over by Pfizer. On October 1st of 2018, investors made 91% in one morning - when Tesaro was taken over by Glaxo. On January 4th, 2019, investors made 71% in one morning - when Loxo Oncology was taken over by Eli Lilly. Sincerely, Brad Sullivan
Publisher
Behind the Markets
| | | | | | This is a PAID ADVERTISEMENT provided to customers of Schaeffer's Investment Research. Although we have sent you this email, Schaeffer's does not specifically endorse this product nor is it responsible for the content of this advertisement. Furthermore, we make no guarantee or warranty about what is advertised above. Your privacy is very important to us, if you wish to be excluded from future notices, do not reply to this message. Instead, please click here.
Schaeffer's Investment Research
5151 Pfeiffer Road, Suite 250
Cincinnati, Ohio 45242
Privacy Policy | | |
No comments:
Post a Comment